Kibow Biotech Launches Limited Human Clinical Trial in North America of Its Probiotic, Kibow Biotics, in Kidney Failure PHILADELPHIA, July 16, 2007 (PRIME NEWSWIRE) -- Kibow Biotech announced today that it has initiated a limited, pilot-scale, double-blind, placebo-controlled, cross-over, six-month human clinical trial...

Kibow Biotech to Participate and Exhibit at Forthcoming American Society of Nephrology Annual Meeting in Philadelphia, Nov. 10-12 PHILADELPHIA, Nov. 1, 2005 (PRIMEZONE) -- Kibow Biotech Inc. is pleased to announce its continued exhibit participation at the American Society of Nephrology's (ASN) 38th annual Meeting &...